No phaseStatus unknownAge-related condition
Treatment of dementia with mandookaparNi leaves after suitable preparation of the patient.
A Pilot Interventional Study on Patient Preparation and Treatment Protocol for the Use of Mandookaparni, Centella asiatica, in Patients with Alzheimers Disease and Significant MCI, Mild Cognitive Impairment.
- Sponsor
- Centre for Brain Research
- Enrollment
- 48 planned
- Conditions
- Health Condition 1: F72- Severe intellectual disabilities
- Registry
- CTRI-2026-10-119011
Full record on the Clinical Trials Registry – IndiaSource: WHO ICTRP, processed October 5, 2026
Primary outcomes
- For MCI patients, cognitive scores on international standard SLUMS and SATURN cognitive assessment <br/ > forms will be the outcome measurement, along with additional assessment by the project designated <br/ > psychiatrists. <br/ > <br/ > For Alzheimers patients, thus the outcome measurement will h
History
Started
Registered
Last registry update